Ftse Mib
37.026,11
1,22%
DAX
21.880,35
1,52%
S&P 500
6.068,81
0,12%
NASDAQ
19.765,55
0,37%
Bitcoin
97.595,92
1,01%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Regno Unito LSE Angle Plc (AGL) Angle Plc (AGL) Notizie

Angle Plc

AGL
16,00
0,30 (1,91%)
Ultimo aggiornamento: 15:59:16
Dati in Delay di 15 minuti
Borsa: Londra
Tipo: Azione Ordinaria
Valuta: GBX

Ultime notizie

Data Ora Fonte Titolo
06/2/202508:00LSEG_NONAngle PLC Novel findings using Parsortix
29/1/202517:26ALNCNewsAngle reports breakthrough in dual cancer DNA analysis
29/1/202508:00LSEG_RNSAngle PLC Analysis of CTC-DNA and ctDNA using Illumina assay
24/1/202511:05LSEG_NONAngle PLC Parsortix used in research paper from ETH Zurich
23/1/202515:22ALNCNewsAngle fails to win market confidence despite narrowing loss..
23/1/202508:00LSEG_RNSAngle PLC Trading Update
13/12/202409:43LSEG_NONAngle PLC HER2 presentation at SABCS
15/11/202415:33ALNCNewsAngle stock surges as firm showcases new assay products
15/11/202408:00LSEG_NONAngle PLC Parsortix based PD-L1 assay showcased at AACR
15/11/202408:00LSEG_NONAngle PLC Research on HER2 assay kit showcased at AACR
13/11/202408:00LSEG_NONAngle PLC ANGLE presents two posters at EACR
11/11/202413:07ALNCNewsAngle notes use of Parsortix system in treatment resistance..
11/11/202408:00LSEG_NONAngle PLC Parsortix enriched CTC & ctDNA in NSCLC patients
17/10/202408:00LSEG_NONAngle PLC Publication demonstrates CTC profiling potential
26/9/202414:30ALNCNewsEARNINGS: Ebiquity bemoans poor conditions on swing to..
26/9/202408:01LSEG_NONAngle PLC 100th publication supporting Parsortix system use
26/9/202408:00LSEG_RNSAngle PLC Half-year Report
23/9/202408:00LSEG_RNSAngle PLC Exclusive agreement for DNA NGS panel
19/9/202415:44ALNCNewsIN BRIEF: Angle celebrates agreement with Recursion..
19/9/202408:00LSEG_NONAngle PLC Agreement with Recursion Pharmaceuticals
17/9/202408:00LSEG_RNSAngle PLC Notice of Interim Results and Webcast
23/8/202412:43ALNCNewsIN BRIEF: Angle hails publication of research data in..
22/8/202408:00LSEG_NONAngle PLC Data supporting FDA approval published in Journal
01/8/202408:00LSEG_NONAngle PLC Independent Parsortix study
18/7/202411:08LSEG_RNSAngle PLC Standard form for notification of major holdings
12/7/202416:38LSEG_RNSAngle PLC Standard form for notification of major holdings
11/7/202416:07LSEG_RNSAngle PLC Result of 2024 Annual General Meeting
21/6/202411:52ALNCNewsIN BRIEF: Angle says open offer raises proceeds of..
21/6/202408:00LSEG_RNSAngle PLC Result of open offer
18/6/202415:41LSEG_RNSAngle PLC Posting of 2023 Annual Report & Notice of the AGM
11/6/202408:00LSEG_NONAngle PLC Parsortix and assays being showcased at EACR 2024
06/6/202417:37LSEG_RNSAngle PLC Publication of Circular
05/6/202417:32ALNCNewsEARNINGS AND TRADING: STV sees advertising upturn; Angle..
05/6/202417:04LSEG_RNSAngle PLC Results of placing and subscription
05/6/202408:00LSEG_RNSAngle PLC Proposed Placing, Subscription and Open Offer
05/6/202408:00LSEG_RNSAngle PLC Preliminary Results
16/5/202421:09ALNCNewsTRADING UPDATES: Bens Creek considers administration; Nexxen..
16/5/202408:00LSEG_NONAngle PLC Study of ovarian cancer CTCs using Parsortix
03/5/202413:17ALNCNewsCORRECT: Angle shares up on assay development deal with..
03/5/202412:50ALNCNewsAngle shares up on assay development deal with AstraZenaca
03/5/202408:00LSEG_RNSAngle PLC New commercial agreement with large pharma
24/4/202411:32ALNCNewsAngle shares jump on supplier agreement with with..
24/4/202408:00LSEG_RNSAngle PLC New commercial agreement with AstraZeneca
22/4/202417:52ALNCNewsIN BRIEF: Angle granted patents in US and Europe for..
22/4/202408:00LSEG_RNSAngle PLC US and EU patents for innovative CellKeep™ slide
08/4/202408:00LSEG_NONAngle PLC Parsortix HER2 assay showcased at AACR 2024
22/3/202408:00LSEG_NONAngle PLC Parsortix at European breast cancer conference
Apertura: 17,25 Min: 15,75 Max: 17,25
Chiusura: 15,70

La tua Cronologia

LSE
AGL
Angle
LSE
B052
Acgb Ltd 24
COIN
BASEUSD
Base Protocol
BIT
I09325
Intesa Sanpaolo
LSE
0OQQ
Infotel
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci